Aequus and Scientus Agree to Terms for a Medical Cannabis Commercial Supply and Product Development Collaboration - Seite 2

"Our product pipeline includes a range of dosing forms in solid, liquid and aerosolized forms targeting a number of indications, including neuropathic pain. We are excited about broadening that pipeline to include transdermal technologies through a collaboration with Aequus," said Trevor Folk, President and CEO of Scientus. "Transdermal approaches have significant potential for safe, effective therapies in a number of disease indications and we are looking forward to leveraging Aequus' expertise to advance the science in the area of refractive epilepsy."

The economics of each product development program under this agreement will be allocated based on the respective party's contribution of funding, resources and intellectual property made during product development.

About Aequus Pharmaceuticals

Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus' development stage pipeline includes several products in neurology and psychiatry with a goal of addressing the need for improved medication adherence through enhanced delivery systems. Aequus intends to commercialize its internal programs in Canada alongside its current portfolio of marketed established medicines and will look to form strategic partnerships that would maximize the reach of its product candidates worldwide. Aequus plans to build on its Canadian commercial platform through the launch of additional products that are either created internally or brought in through an acquisition or license; remaining focused on highly specialized therapeutic areas. For further information, please visit www.aequuspharma.ca.

About Scientus

Scientus Pharma is a vertically-integrated biopharmaceutical Licensed Dealer under the Narcotics Control Regulations of Canada with a focus on developing and commercializing pharmaceutical-grade cannabinoid derivative products. Being one of a limited number of Licensed Dealers in Canada authorized to handle cannabinoid products, Scientus Pharma has the ability to wholesale, buy, process and sell cannabinoid derivatives, from and to Licensed Producers, as well as international markets.